Stock analysis, trade plans, and proprietary indicators by Trend Edge.
Trend Edge Setup Score
Trend Edge rates CABA Bullish with a Setup Score of 0, net conviction 30, actionability 0. How the Setup Score works →
Total Setup Score
0
Directional Bias
Bullish
Net Conviction
30
Actionability
0 (no mans land)
Key signals behind this score
Funds accumulating
Founder-led
Uptrend (80wk)
Shorts covering
About Cabaletta Bio Inc
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with autoimmune diseases. The company's lead product candidate is resecabtagene autoleucel, a 4-1BB co-stimulatory domain-containing fully human CD19-CAR T, which is in Phase 1/2 clinical trials for the treatment of dermatomyositis, anti-synthetase syndrome, immune-mediated necrotizing myopathy, juvenil… Read full Trend Edge analysis →
Sector: Healthcare
Industry: Biotechnology
Exchange: NASDAQ
IPO Date: October 25, 2019
Headquarters: 2929 Arch Street, Philadelphia, PA, United States, 19104
Founder-Led: Yes — Steven Nichtberger (President, Chief Executive Officer, and Co-Founder)
Key Metrics
Current Price
$0.94
Market Cap
$218M
Float
192.9M
Shares Outstanding
215.7M
vs. Analyst Target
+1150.0% to analyst PT
Dividend Rate
None
Analyst Target Price
$11.75 (10 analysts)
Financial History
Annual Revenue & Earnings History
Year
Revenue
Net Income
Gross Profit
EBITDA
2020
$0.01
-$32.5M
$0.01
-$33.5M
2021
N/A
-$45.5M
-$733,000
-$45.6M
2022
N/A
-$51.8M
-$3.7M
-$53.0M
2023
N/A
-$67.7M
-$1.4M
-$66.2M
2024
N/A
-$116M
-$4.8M
-$113M
2025
N/A
-$168M
-$1.6M
-$164M
Recent Quarterly Revenue & Net Income
Quarter
Revenue
Net Income
Dec 2025
N/A
-$41.9M
Mar 2026
N/A
-$43.5M
Jun 2026
N/A
-$51.0M
Sep 2026
N/A
-$53.1M
Ownership & Float
Insider Ownership
0.8%
Institutional Ownership
97.3%
Short Float
19.5%
% of All Funds Holding
1.85%
Number of Funds Holding
163
Current Moving Averages
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
Timeframe
SMA
Value
Trend Context
Weekly
10-Week SMA
$1.65
Near-term / short-term trend
Weekly
40-Week SMA
$2.73
Medium-term trend
Weekly
80-Week SMA
$2.44
Cyclical trend (business cycle)
Weekly
200-Week SMA
$7.07
Secular trend (multi-year)
Monthly
10-Month SMA
$2.60
Near-term monthly trend
Monthly
20-Month SMA
$2.35
Medium-term monthly trend
Monthly
40-Month SMA
$6.27
Secular monthly trend
Volume Shelves — Support & Resistance
Trend Edge identifies volume shelves: price zones where historically elevated trading volume
creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative
volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
Price Level
Type
Volume Ratio
Age
$1.90
resistance
1.30x
0 months ago
$3.00
resistance
1.67x
1 months ago
$5.00
resistance
2.01x
22 months ago
Historical Earnings Reactions (29 events)
Timeframe
Avg Return
Median
Win Rate
Best
Worst
Gap
0.85%
0.14%
51.72%
6.06%
-2.13%
1 Day
0.52%
1.18%
58.62%
17.24%
-19.84%
1 Week
-0.86%
-4.61%
37.93%
91.63%
-50.53%
2 Weeks
3.12%
4.45%
55.17%
74.88%
-31.25%
1 Month
6.42%
-0.95%
46.43%
235.47%
-39.72%
Next earnings: January 24, 2027 (62 days away)
Seasonality & Day-of-Week Patterns
Monthly Seasonality
Month
Avg Return
Win Rate
Samples
Jan
6.6%
71.4%
7
Feb
-9.3%
28.6%
7
Mar
-18.5%
14.3%
7
Apr
-5.4%
42.9%
7
May
10.5%
57.1%
7
Jun
-6.6%
28.6%
7
Jul
-1.8%
42.9%
7
Aug
0.6%
42.9%
7
Sep
0.7%
57.1%
7
Oct
25.9%
57.1%
7
Nov
28.6%
71.4%
7
Dec
1.6%
42.9%
7
Day-of-Week Tendencies
Day
Avg Return
Win Rate
Samples
Monday
0.30%
44.4%
333
Tuesday
-0.34%
47.1%
367
Wednesday
0.16%
45.5%
363
Thursday
0.19%
46.9%
356
Friday
0.31%
45.2%
354
Top Institutional Holders
Institutional holder breakdown coming soon.
Total institutional ownership: 97.3%
Insider Transactions — Smart Summary
Total insider ownership: 0.8%
Founder-led management: Steven Nichtberger (President, Chief Executive Officer, and Co-Founder)
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Cabaletta Bio Inc
(CABA) powered by Claude Opus — Anthropic's most capable AI model.
The analysis covers five layers:
technical analysis (near-term, medium-term, cyclical, and secular trend, momentum,
volume shelf support and resistance, breakout and breakdown signals),
qualitative analysis (business model, competitive moat, sector dynamics),
insider sentiment (buy and sell signals from executive and director transactions),
share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and
fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit,
stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward.
Whether you are building a long position, initiating a short, or looking for a reversal setup,
AI Consult identifies the highest-probability signal from the current trend.